M&ABusinessLine
Sai Parenterals to buy majority stake in Bion Therapeutics
Positive+67
GreyOak summary
Sai Parenterals plans to acquire a majority stake in Hyderabad-based Bion Therapeutics through its subsidiary SP Analytics. The all-cash deal, expected to close by month-end, will make Bion a step-down subsidiary.
What it affects
- Sai ParenteralsSAIPARENTPositive +67
Acquiring majority stake in Bion Therapeutics.Rolling sentiment Positive +42
Source
Read the original at BusinessLineMore Sai Parenterals news
No other recent stories about Sai Parenterals.
All Sai Parenterals news →